Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

Recruiting

• Conditions: Del(17P); Chronic Lymphocytic Leukemia

• Registration Number: NCT03197259
• Lead Sponsor: Fatih Demirkan, MD

Brief Summary

A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey

Detailed Description

The purpose of this study is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

Study Timeline

• Study Start: 2017-01-01
• Study First Submitted: 2017-05-18
• Study First Submitted QC: 2017-06-21
• Study First Posted: 2017-06-23
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-08
• Last Update Posted: 2021-03-09
• Primary Completion: 2023-01-01
• Study Completion: 2026-08-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients diagnosed as CLL
• 18 years or older
• Able and willing to provide the written informed consent

Exclusion Criteria

• Younger than 18 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
First line therapy therapy protocol distrubition	36 months	The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting

Trial Locations

Locations (1)

Dokuz Eylum Medical Favulty; 🇹🇷 Izmir, Turkey